Ameriprise Financial Inc Adaptive Biotechnologies Corp Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 82,411 shares of ADPT stock, worth $386,507. This represents 0.0% of its overall portfolio holdings.

Number of Shares
82,411
Previous 50,909 61.88%
Holding current value
$386,507
Previous $184,000 128.8%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.37 - $5.12 $106,161 - $161,290
31,502 Added 61.88%
82,411 $421,000
Q2 2024

Aug 14, 2024
SELL
$2.34 - $3.96 $1.86 Million - $3.15 Million
-795,470 Reduced 93.99%
50,909 $184,000
Q1 2024

May 15, 2024
BUY
$2.88 - $4.8 $2.28 Million - $3.8 Million
791,445 Added 1440.72%
846,379 $2.72 Million
Q4 2023

Feb 14, 2024
SELL
$3.46 - $5.33 $85,410 - $131,571
-24,685 Reduced 31.0%
54,934 $269,000
Q3 2023

Nov 14, 2023
BUY
$5.07 - $8.44 $137,711 - $229,247
27,162 Added 51.78%
79,619 $433,000
Q2 2023

Aug 14, 2023
SELL
$6.19 - $8.78 $2.32 Million - $3.3 Million
-375,507 Reduced 87.74%
52,457 $351,000
Q1 2023

May 15, 2023
BUY
$7.8 - $10.11 $460,699 - $597,137
59,064 Added 16.01%
427,964 $3.78 Million
Q4 2022

Feb 14, 2023
BUY
$6.26 - $9.34 $2.31 Million - $3.45 Million
368,900 New
368,900 $2.82 Million
Q2 2022

Aug 15, 2022
SELL
$6.4 - $14.73 $4.15 Million - $9.55 Million
-648,479 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$10.12 - $28.9 $690,234 - $1.97 Million
68,205 Added 11.75%
648,479 $9 Million
Q4 2021

Feb 14, 2022
SELL
$25.17 - $36.85 $5,688 - $8,328
-226 Reduced 0.04%
580,274 $16.3 Million
Q3 2021

Nov 15, 2021
BUY
$30.02 - $39.87 $1.42 Million - $1.89 Million
47,418 Added 8.9%
580,500 $19.7 Million
Q2 2021

Aug 16, 2021
SELL
$32.22 - $44.59 $10.3 Million - $14.3 Million
-319,950 Reduced 37.51%
533,082 $21.8 Million
Q1 2021

May 17, 2021
BUY
$37.26 - $67.74 $3.63 Million - $6.6 Million
97,490 Added 12.9%
853,032 $34.3 Million
Q4 2020

Feb 12, 2021
BUY
$45.01 - $65.47 $7.39 Million - $10.7 Million
164,134 Added 27.75%
755,542 $44.7 Million
Q3 2020

Nov 16, 2020
BUY
$35.79 - $48.81 $8.81 Million - $12 Million
246,292 Added 71.36%
591,408 $28.8 Million
Q2 2020

Aug 14, 2020
BUY
$24.95 - $48.38 $310,502 - $602,089
12,445 Added 3.74%
345,116 $16.7 Million
Q1 2020

May 15, 2020
BUY
$16.96 - $34.16 $776,988 - $1.56 Million
45,813 Added 15.97%
332,671 $9.24 Million
Q4 2019

Feb 14, 2020
BUY
$24.56 - $32.8 $841,327 - $1.12 Million
34,256 Added 13.56%
286,858 $8.58 Million
Q3 2019

Nov 14, 2019
BUY
$30.31 - $53.51 $2.79 Million - $4.92 Million
92,005 Added 57.29%
252,602 $7.81 Million
Q2 2019

Aug 14, 2019
BUY
$40.3 - $48.3 $6.47 Million - $7.76 Million
160,597 New
160,597 $7.76 Million

Others Institutions Holding ADPT

# of Institutions
201
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $670M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email